Auro Laboratories Limited (BOM:530233)
235.50
-0.30 (-0.13%)
At close: Aug 21, 2026
Auro Laboratories Revenue
Auro Laboratories had revenue of 88.76M INR in the quarter ending June 30, 2026, with 219.96% growth. This brings the company's revenue in the last twelve months to 364.26M, up 121.40% year-over-year. In the fiscal year ending March 31, 2026, Auro Laboratories had annual revenue of 307.40M with 60.74% growth.
Revenue (ttm)
364.26M
Revenue Growth
+121.40%
P/S Ratio
4.00
Revenue / Employee
4.71M
Employees
78
Market Cap
1.47B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 307.40M | 116.16M | 60.74% |
| Mar 31, 2025 | 191.24M | -345.11M | -64.34% |
| Mar 31, 2024 | 536.35M | 7.41M | 1.40% |
| Mar 31, 2023 | 528.94M | 20.28M | 3.99% |
| Mar 31, 2022 | 508.66M | -33.86M | -6.24% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aarey Drugs & Pharmaceuticals | 4.15B |
| Smruthi Organics | 1.12B |
| Kimia Biosciences | 1.12B |
| Panchsheel Organics | 1.08B |
| Resonance Specialties | 1.02B |
| Tyche Industries | 500.33M |
| Vasundhara Rasayans | 350.94M |
| Crestchem | 338.33M |
Auro Laboratories News
- 1 year ago - Shaan Jain resigns as CFO of Auro Laboratories, effective December 18, 2024 - Business Upturn